Alterity Therapeutics (ATHE) Other Working Capital Changes (2009 - 2020)
Alterity Therapeutics' (ATHE) quarterly Other Working Capital Changes came in at $10868.2 in Q2 2020, down 67.24% year-on-year from $33175.8 in Q3 2019, and down 70.78% quarter-over-quarter from $37197.6 in Q4 2019.
Alterity Therapeutics (ATHE) Other Working Capital Changes (2009 - 2020) Analysis & Trends
Alterity Therapeutics' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $10868.2 for Q2 2020.
- On a quarterly basis, Other Working Capital Changes fell 67.24% year-over-year to $10868.2 in Q2 2020; TTM through Jun 2020 was $108616.7, a 25.83% decrease from a year earlier, with the FY2025 full-year figure at $221083.3, up 253.88% from the prior year.
- Other Working Capital Changes slipped to $10868.2 in Q2 2020 per ATHE's latest filing, from $37197.6 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $46670.6 in Q4 2017 and bottomed at -$255773.2 in Q2 2019.
- The 5-year median for Other Working Capital Changes is -$86350.9 (2016), against an average of -$77106.7.
- Across the five-year window, Other Working Capital Changes tumbled 647.28% in 2016 and jumped 4125.31% in 2019, its largest moves.
- Year by year, Other Working Capital Changes stood at -$90727.9 in 2016, then surged by 195.57% to $86708.3 in 2017, then sank by 68.43% to $27375.1 in 2018, then soared by 35.88% to $37197.6 in 2019, then sank by 70.78% to $10868.2 in 2020.
- Per Business Quant, the three latest ATHE Other Working Capital Changes figures stand at $10868.2 (Q2 2020), $37197.6 (Q4 2019), and $33175.8 (Q2 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 10,868.18 |
| Jun 30, 2020 | 10,868.18 |
| Jun 30, 2020 | 10,868.18 |
| Dec 31, 2019 | 37,197.59 |
| Dec 31, 2019 | 37,197.59 |
| Dec 31, 2019 | 37,197.59 |
| Jun 30, 2019 | 33,175.77 |
| Jun 30, 2019 | 33,175.77 |
| Jun 30, 2019 | 33,175.77 |
| Dec 31, 2018 | 27,375.13 |
| Dec 31, 2018 | 27,375.13 |
| Dec 31, 2018 | 27,375.13 |
| Jun 30, 2018 | -824.18 |
| Jun 30, 2018 | -824.18 |
| Jun 30, 2018 | -824.18 |
| Dec 31, 2017 | 86,708.33 |
| Dec 31, 2017 | 86,708.33 |
| Dec 31, 2017 | 86,708.33 |
| Jun 30, 2017 | 67,035.76 |
| Jun 30, 2017 | 67,035.76 |